{"altmetric_id":1029230,"counts":{"readers":{"mendeley":36,"citeulike":0,"connotea":0},"blogs":{"unique_users_count":1,"unique_users":[201],"posts_count":1},"total":{"posts_count":1}},"citation":{"abstract":"Human respiratory syncytial virus (RSV) infection is a major cause of morbidity in children and of morbidity and mortality in elderly or immunocompromised adults. Given prophylactically, antibody can protect against infection, but natural levels are poorly protective. Vaccination may enhance disease, and there is no well tolerated and effective vaccine or antiviral treatment. Despite over 50 years of research, therapy remains nonspecific and supportive.","abstract_source":"pubmed","altmetric_jid":"4f6fa5e63cf058f610005861","authors":["Habibi MS","Openshaw PJ"],"doi":"10.1097\/qco.0b013e32835a1d92","first_seen_on":"2012-10-29T17:47:27+00:00","funders":["wellcome","mrc"],"issns":["0951-7375"],"issue":"","journal":"Current opinion in infectious diseases","last_mentioned_on":1351526100,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23086186"],"pmid":"23086186","pubdate":"2012-10-24T00:00:00+00:00","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"},{"name":"Medical Microbiology","scheme":"era"},{"name":"Microbiology","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"subjects":["communicablediseases"],"title":"Benefit and harm from immunity to respiratory syncytial virus: implications for treatment.","type":"article","volume":"","mendeley_url":"http:\/\/www.mendeley.com\/research\/benefit-harm-immunity-respiratory-syncytial-virus-implications-treatment"},"altmetric_score":{"score":5.632,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":5.632},"context_for_score":{"all":{"total_number_of_other_articles":3685988,"mean":4.9540738657005,"rank":535138,"this_scored_higher_than_pct":85,"this_scored_higher_than":3150652,"rank_type":"exact","sample_size":3685988,"percentile":85},"similar_age_3m":{"total_number_of_other_articles":78960,"mean":5.139113565268,"rank":11765,"this_scored_higher_than_pct":85,"this_scored_higher_than":67192,"rank_type":"exact","sample_size":78960,"percentile":85},"this_journal":{"total_number_of_other_articles":317,"mean":2.5573670886076,"rank":29,"this_scored_higher_than_pct":90,"this_scored_higher_than":287,"rank_type":"exact","sample_size":317,"percentile":90},"similar_age_this_journal_3m":{"total_number_of_other_articles":14,"mean":3.7807692307692,"rank":4,"this_scored_higher_than_pct":71,"this_scored_higher_than":10,"rank_type":"exact","sample_size":14,"percentile":71}}},"demographics":{"users":{"mendeley":{"by_status":{"Professor > Associate Professor":5,"Student  > Doctoral Student":1,"Researcher":7,"Student  > Ph. D. Student":8,"Student  > Postgraduate":2,"Other":4,"Student  > Master":3,"Student  > Bachelor":4,"Professor":2},"by_discipline":{"Medicine and Dentistry":17,"Social Sciences":1,"Physics and Astronomy":1,"Immunology and Microbiology":2,"Economics, Econometrics and Finance":1,"Agricultural and Biological Sciences":11,"Biochemistry, Genetics and Molecular Biology":1,"Unspecified":2}}},"geo":{"mendeley":{"NL":1,"AU":1}}},"posts":{"blogs":[{"title":"Benefit and harm from immunity to respiratory syncytial virus","url":"http:\/\/www.microbiologybytes.com\/blog\/2012\/10\/29\/benefit-and-harm-from-immunity-to-respiratory-syncytial-virus\/?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+Microbiologybytes+%28MicrobiologyBytes%29","citation_ids":[1029230],"posted_on":"2012-10-29T15:55:00+00:00","summary":"Respiratory syncytial virus (RSV) is the major cause of bronchiolitis, itself the commonest single cause of hospitalization during infancy. The WHO estimates that RSV infects 34 million children under 5 years of age every year, accounts for 22% of all acu","author":{"name":"MicrobiologyBytes","url":"http:\/\/www.microbiologybytes.com\/blog","description":"The latest news about microbiology"}}]}}